Abstract
This corrects the article DOI: 10.3389/fnhum.2025.1544994.
Introduction
In the rapidly evolving landscape of neurotechnology, the annual Deep Brain Stimulation (DBS) Think Tank serves as a critical forum for multidisciplinary collaboration. These meetings bring together experts in neurology, neurosurgery, engineering, and ethics to discuss the latest advancements in "closed-loop" systems and novel clinical applications. This document is a formal corrigendum for the proceedings of the 12th annual Think Tank, issued to ensure the accuracy and integrity of the published author record.
The Correction: Author Attribution
The primary purpose of this corrigendum is to rectify an administrative omission in the original publication (DOI: 10.3389/fnhum.2025.1544994). Specifically, researcher Sarah-Anna Hescham, affiliated with Maastricht University and RWTH Aachen University Hospital, was inadvertently excluded from the list of contributors.
In high-stakes academic publishing, the author list is the primary currency of credit and accountability. Large-scale collaborative efforts, such as the DBS Think Tank, involve dozens of experts whose contributions are essential to the final synthesis of ideas. This correction ensures that Dr. Hescham receives proper credit for her work on the proceedings.
Scope of the 12th Annual DBS Think Tank
The sheer breadth of the author list—comprising over 50 researchers from prestigious institutions like Georgia Tech, Duke, UCLA, and the University of Florida—underscores that DBS research has moved far beyond simple surgical intervention. The field is now a complex intersection of advanced signal processing, neuroethics, and personalized medicine.
The original proceedings detailed technological roadmaps and clinical challenges across a wide spectrum of disorders. Key areas of focus included:
- Movement Disorders and Beyond: While Parkinson’s disease remains a core focus, the community is aggressively expanding into psychiatric applications such as depression and obsessive-compulsive disorder (OCD).
- Neurological Recovery: Investigating the role of neuromodulation in treating epilepsy and aiding recovery from stroke.
- Physiological Regulation: Exploring DBS applications for sleep disorders.
- Cutting-Edge Technology: Discussions centered on directional leads, sensing-enabled neurostimulators, and the emerging field of personalized "connectomic" DBS.
Scientific Integrity and Future Work
The authors and the editorial board of Frontiers in Human Neuroscience explicitly state that this correction is administrative in nature and "does not change the scientific conclusions of the article in any way." This assurance is vital for maintaining trust in the published data and technological roadmaps.
The existence of this annual forum implies that the field is actively grappling with current limitations, such as hardware battery life, electrode placement accuracy, and the ethical implications of modulating human cognition. Future proceedings will likely continue to push the boundaries of how technology can interface with the human brain to treat complex neurological and psychiatric conditions.
Conclusion
This corrigendum successfully updates the public record to include Sarah-Anna Hescham in the proceedings of the 12th annual DBS Think Tank. By ensuring accurate attribution, the journal maintains the high standards of scientific integrity required for such a significant multidisciplinary effort.
Original Article DOI: 10.3389/fnhum.2025.1544994
Summary updated